Q&A With September’s Featured Editor: Josh Whitehill Josh Whitehill is an associate in Goodwin’s New York office. BMW: Where would we find you on a Saturday afternoon? Josh: On a…
Q&A With September’s Featured Editor: Josh Whitehill Josh Whitehill is an associate in Goodwin’s New York office. BMW: Where would we find you on a Saturday afternoon? Josh: On a…
Today, the U.S. FDA released its Biosimilar Action Plan (BAP), which outlines the Administration’s proposed next steps to help reduce the costs of healthcare by expediting the development of…